# EDGAR Filing Document

**Accession Number:** 0002035832
**File Stem:** 0001354457-26-000020
**Filing Date:** 2026-1
**Character Count:** 1142
**Document Hash:** 4f2b87c8ab795389eb54efda066c83cb
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001354457-26-000020.hdr.sgml**: 20260108

**ACCESSION NUMBER**: 0001354457-26-000020

**CONFORMED SUBMISSION TYPE**: CERT

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260108

**DATE AS OF CHANGE**: 20260108

**EFFECTIVENESS DATE**: 20260108

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Aktis Oncology, Inc.
- **CENTRAL INDEX KEY:** 0002035832
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 852584233
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** CERT
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43047
- **FILM NUMBER:** 26518389

**BUSINESS ADDRESS:**
- **STREET 1:** 17 DRYDOCK AVENUE
- **STREET 2:** SUITE #17-401
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210
- **BUSINESS PHONE:** 978-237-4380

**MAIL ADDRESS:**
- **STREET 1:** 17 DRYDOCK AVENUE
- **STREET 2:** SUITE #17-401
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02210

### Attached PDF Documents

**Attachment 1:** `8A_Cert_AKTS_0002035832.pdf`

_No text found in this document._